LDR Holding Corp. Acquisition May Not Be in the Best Interests of LDRH Shareholders
NEW YORK, June 9, 2016 /PRNewswire-USNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of LDR Holding Corp. ("LDRH" or the "Company") in connection with the proposed acquisition of the Company by Zimmer Biomet Holdings Inc. ("Zimmer Biomet"). On June 7, 2016, the Company announced it had reached a definitive agreement for Zimmer Biomet to acquire all outstanding shares of LDRH in a transaction valued at approximately $1 billion. Under the terms of the agreement, LDRH shareholders will receive $37.00 in cash for each LDRH share they own.
WeissLaw is investigating whether LDRH's Board acted to maximize shareholder value prior to entering into the agreement. Notably, at least one analyst set a target price of $40.00 per share, or $3.00 above the offer price. Additionally, the Company recently reported positive financial results for the first quarter of 2016. It reported total revenues of $42.4 million. This represents an 8.4% increase year-over-year when compared the $39.1 reported in the same period of the previous year. Finally, the offer price is significantly lower than the Company's 52-week high of $47.12.
Given these facts, WeissLaw is investigating whether LDRH's Board acted in the best interests of LDRH's public shareholders to maximize shareholder value prior to entering into the agreement. If you own LDRH shares and would like more information about your rights or our investigation, or if you have information to share with us, please contact Joshua Rubin by telephone at (888) 593-4771 or by email at [email protected].
WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at [email protected] or fill out the form on our website, http://www.weisslawllp.com/contact/report_fraud/.
SOURCE WeissLaw LLP
Share this article